| Richard L Russell, MD | |
|
106 Highland Way Ste 200, Madison, MS 39110-6933 | |
| (601) 200-4141 | |
| (601) 200-4150 |
| Full Name | Richard L Russell |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 30 Years |
| Location | 106 Highland Way Ste 200, Madison, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063584175 | NPI | - | NPPES |
| 00126047 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 14431 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sta Home Health And Hospice | Clinton, MS | Home health agency |
| Mississippi Homecare Of Jackson | Jackson, MS | Home health agency |
| Kindred At Home -flowood | Flowood, MS | Home health agency |
| St Dominic-jackson Memorial Hospital | Jackson, MS | Hospital |
| Mississippi Baptist Medical Center | Jackson, MS | Hospital |
| Mississippi Methodist Rehab Ctr | Jackson, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St. Dominic Medical Associates Llc | 0446303168 | 154 |
News Archive
Today, tablets are ubiquitous. While many of us reach for them to scan Facebook, watch the newest series on Netflix, or make a quick purchase on Amazon, researchers want to test their potential for a more serious task: detecting atrial fibrillation (afib).
Phase Forward, a leading provider of data solutions for clinical trials and drug safety, today announced the availability of version 7.2 of its Empirica™ Signal product, a significant new release of the company's flagship signal detection and management software. The Empirica Signal solution is a state-of-the-art data mining and knowledge management tool and a cornerstone component of Phase Forward's Empirica Suite of pharmacovigilance and risk management products.
Myopia or short-sightedness is becoming more common across Europe, according to a new study led by King's College London. The meta-analysis of findings from 15 studies by the European Eye Epidemiology Consortium found that around a quarter of the European population is short-sighted but it is nearly twice as common in younger people, with almost half (47 per cent) of the group aged between 25 and 29 years affected.
Preliminary research suggests that testosterone replacement therapy for men with low testosterone levels appears to have little effect on the prostate gland, contrary to some reports that this therapy may be harmful, according to a study in the November 15 issue of JAMA: The Journal of the American Medical Association.
ECRI, a nonprofit health services research agency, recently published a Health Technology Forecast profile on a novel pharmaceutical agent that is in development for the treatment of obesity.
› Verified 2 days ago
| Entity Name | St. Dominic Medical Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407920549 PECOS PAC ID: 0446303168 Enrollment ID: O20090728000821 |
News Archive
Today, tablets are ubiquitous. While many of us reach for them to scan Facebook, watch the newest series on Netflix, or make a quick purchase on Amazon, researchers want to test their potential for a more serious task: detecting atrial fibrillation (afib).
Phase Forward, a leading provider of data solutions for clinical trials and drug safety, today announced the availability of version 7.2 of its Empirica™ Signal product, a significant new release of the company's flagship signal detection and management software. The Empirica Signal solution is a state-of-the-art data mining and knowledge management tool and a cornerstone component of Phase Forward's Empirica Suite of pharmacovigilance and risk management products.
Myopia or short-sightedness is becoming more common across Europe, according to a new study led by King's College London. The meta-analysis of findings from 15 studies by the European Eye Epidemiology Consortium found that around a quarter of the European population is short-sighted but it is nearly twice as common in younger people, with almost half (47 per cent) of the group aged between 25 and 29 years affected.
Preliminary research suggests that testosterone replacement therapy for men with low testosterone levels appears to have little effect on the prostate gland, contrary to some reports that this therapy may be harmful, according to a study in the November 15 issue of JAMA: The Journal of the American Medical Association.
ECRI, a nonprofit health services research agency, recently published a Health Technology Forecast profile on a novel pharmaceutical agent that is in development for the treatment of obesity.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard L Russell, MD Po Box 23666, Jackson, MS 39225-3666 Ph: (601) 200-4749 | Richard L Russell, MD 106 Highland Way Ste 200, Madison, MS 39110-6933 Ph: (601) 200-4141 |
News Archive
Today, tablets are ubiquitous. While many of us reach for them to scan Facebook, watch the newest series on Netflix, or make a quick purchase on Amazon, researchers want to test their potential for a more serious task: detecting atrial fibrillation (afib).
Phase Forward, a leading provider of data solutions for clinical trials and drug safety, today announced the availability of version 7.2 of its Empirica™ Signal product, a significant new release of the company's flagship signal detection and management software. The Empirica Signal solution is a state-of-the-art data mining and knowledge management tool and a cornerstone component of Phase Forward's Empirica Suite of pharmacovigilance and risk management products.
Myopia or short-sightedness is becoming more common across Europe, according to a new study led by King's College London. The meta-analysis of findings from 15 studies by the European Eye Epidemiology Consortium found that around a quarter of the European population is short-sighted but it is nearly twice as common in younger people, with almost half (47 per cent) of the group aged between 25 and 29 years affected.
Preliminary research suggests that testosterone replacement therapy for men with low testosterone levels appears to have little effect on the prostate gland, contrary to some reports that this therapy may be harmful, according to a study in the November 15 issue of JAMA: The Journal of the American Medical Association.
ECRI, a nonprofit health services research agency, recently published a Health Technology Forecast profile on a novel pharmaceutical agent that is in development for the treatment of obesity.
› Verified 2 days ago
Mr. Alexander Chapman Whittington, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 401 Baptist Dr Ste 201, Madison, MS 39110 Phone: 601-853-2020 Fax: 601-853-2728 | |
Dr. Jerry Scott Harrison, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 106 Highland Way Ste 200, Madison, MS 39110 Phone: 601-200-4141 Fax: 601-200-4150 | |
Dr. Seth Alan Compton, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 401 Baptist Dr Ste 401, Madison, MS 39110 Phone: 601-973-1571 Fax: 601-973-1623 | |
Howard D Dear, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 401 Baptist Dr, #304, Madison, MS 39110 Phone: 601-605-3531 Fax: 601-605-3532 | |
Stevan Webster, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 216 Kingsbridge Rd, Madison, MS 39110 Phone: 601-862-7660 | |
Dr. James Kevin Bridges, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 920 Ebenezer Blvd Ste A, Madison, MS 39110 Phone: 769-200-1600 Fax: 769-200-1571 |